Clinical Trial Update: Effect of Add-on Montelukast to Inhaled Corticosteroids on Airway Responsiveness [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluated adding montelukast to inhaled corticosteroids to assess airway responsiveness in asthma. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SINGULAIR (montelukast)

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Asthma | Phase 4 | Status: COMPLETED